Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
DECITABIN Accord Trockensub 50 mg Durchstf
Drug
Decitabin Accord, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Zytostatikum
07.16.1. – cytostatics
HAM – Human medicine
PULPI – powder for concentrate for solution for infusion
S – synthetic products for human use
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
10/19/2022
10/18/2027
Dosage strength
Decitabin Accord 50 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Zytostatikum
01
Z – approved
Package
7680682550012
In trade from / since 10/19/2022
A/R – Authorised / referenced
1 vial(s)
001
Z – approved
Declaration
Component
50 mg decitabinum
kalii dihydrogenophosphas
19.53 mg kalium
natrii hydroxidum
6.67 mg natrium
19.53 mg kalium
natrii hydroxidum
6.67 mg natrium
Spezialitätenliste***
SL
-
-
886.30
None
Yes
10%
Yes
Authorisation holder
7601001405677
Accord Healthcare AG
Wuhrmattstrasse 23
4103 Bottmingen (BL)
Wuhrmattstrasse 23
4103 Bottmingen (BL)
Date of revision of the text
4/29/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.